Daniel S. Jonas - 01 Mar 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Signature
Daniel S. Jonas
Issuer symbol
CNMD
Transactions as of
01 Mar 2023
Net transactions value
-$353,294
Form type
4
Filing time
03 Mar 2023, 15:45:39 UTC
Previous filing
05 Jun 2023
Next filing
04 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +2,500 +20% $0.000000 14,784 01 Mar 2023 Direct
transaction CNMD Common Stock Tax liability $70,774 -736 -5% $96.16 14,048 01 Mar 2023 Direct
transaction CNMD Common Stock Options Exercise $323,784 +5,400 +38% $59.96 19,448 02 Mar 2023 Direct
transaction CNMD Common Stock Sale $519,723 -5,400 -28% $96.24 14,048 02 Mar 2023 Direct
transaction CNMD Common Stock Options Exercise $393,800 +5,000 +36% $78.76 19,048 02 Mar 2023 Direct
transaction CNMD Common Stock Sale $480,381 -5,000 -26% $96.08 14,048 02 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -2,500 -100% $0.000000* 0 01 Mar 2023 Common Stock 2,500 $0.000000 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +3,000 $0.000000 3,000 01 Mar 2023 Common Stock 3,000 $0.000000 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5,400 -100% $0.000000* 0 02 Mar 2023 Common Stock 5,400 $59.96 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5,000 -50% $0.000000 5,000 02 Mar 2023 Common Stock 5,000 $78.76 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period